Emerging drugs for ocular hypertension

AJ Lee, I Goldberg - Expert opinion on emerging drugs, 2011 - Taylor & Francis
Ocular hypertension (OH) occurs where intraocular pressure elevation occurs in the …
Ocular hypotensive medications are the mainstay of glaucoma and OH treatment, and their use …

The ocular hypertension treatment study

MA Kass - Journal of glaucoma, 1994 - journals.lww.com
drug to lower intraocular pressure. Despite the lack of convincing evidence for the efficacy
of medical treatment in ocular … nonetheless being treated with ocular hypotensive drugs. The …

New treatments for ocular hypertension

A Mediero, P Alarma-Estrany, J Pintor - Autonomic Neuroscience, 2009 - Elsevier
… Taking these two aspects into consideration, the present article reviews the involvement of
new substances and new strategies for the treatment of ocular hypertension and glaucoma …

The latest drugs in development that reduce intraocular pressure in ocular hypertension and glaucoma

V Jayanetti, S Sandhu, JA Lusthaus - Journal of Experimental …, 2020 - Taylor & Francis
… Our review focuses upon developing topical ocular hypotensive agents; however, alternative
drug delivery methods are also being explored. In further attempts to mitigate the side …

Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study

…, Ocular Hypertension Treatment Study Group - American journal of …, 2006 - Elsevier
PURPOSE: The Ocular Hypertension Treatment Study (OHTS) demonstrated that medical
treatment of people with intraocular pressure (IOP) of ≥24 mm Hg reduces the risk of the …

The Ocular Hypertension Treatment Study: design and baseline description of the participants

…, Ocular Hypertension Treatment Study … - Archives of …, 1999 - jamanetwork.com
… The drug regimen includes all commercially … ocular hypotensive medication, the incidence
of POAG in individuals with ocular hypertension, and the IOP response to topical ocular

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open …

…, Ocular Hypertension Treatment Study … - Archives of …, 2002 - jamanetwork.com
… In addition, most trials used only 1 drug, so treatment efficacy was reduced by drugocular
hypertension in population-based studies and this study; (2) the burden of long-term treatment, …

Delaying treatment of ocular hypertension

MA Kass, MO Gordon, F Gao, DK Heuer… - Arch …, 2010 - jamanetwork.com
… statistical power of 0.90 to detect a relative risk for treatment of 0.50. We assumed that
treatment with topical ocular hypotensive medication would be initiated in most participants in the …

Pharmacological management of ocular hypertension: current approaches and future prospective

C Bucolo, S Salomone, F Drago, M Reibaldi… - Current opinion in …, 2013 - Elsevier
… endeavors facing the ocular pharmacology scientist. … ocular hypertension with a particular
attention to the novel molecules classified in two major classes: inflow and outflow drugs

Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension

M Batra, S Gupta, AB Nair… - European Journal …, 2021 - journals.sagepub.com
… of netarsudil for the management of ocular hypertension and open-angle glaucoma. … drugs
According 18 to their mechanism of action, drugs used in glaucoma and ocular hypertension